Advertisement
Advertisement
U.S. Markets open in 2 hrs 30 mins
S&P Futures
3,812.25 -15.00 (-0.39%) Dow Futures
30,948.00 -113.00 (-0.36%) Nasdaq Futures
11,560.25 -51.00 (-0.44%) Russell 2000 Futures
1,719.30 -9.20 (-0.53%) Crude Oil
110.30 +1.87 (+1.72%) Gold
1,807.40 +5.90 (+0.33%)
Rigel Pharmaceuticals, Inc. (RIGL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 1.1300 |
| Open | 1.1200 |
| Bid | 1.1700 x 45900 |
| Ask | 1.2000 x 800 |
| Day's Range | 1.1100 - 1.2900 |
| 52 Week Range | 0.6400 - 4.4800 |
| Volume | |
| Avg. Volume | 5,720,475 |
| Market Cap | 213.758M |
| Beta (5Y Monthly) | 1.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0850 |
| Earnings Date | Feb 28, 2022 - Mar 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.14 |
- Simply Wall St.
The President of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Raul Rodriguez, Just Bought 521% More Shares
Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ) shareholders (or potential shareholders) will be happy to see that the...
- Zacks
Biotech Stock Roundup: BLUE Up on Regulatory Updates, RIGL's Pipeline News & More
Regulatory and other updates from bluebird (BLUE) and Rigel (RIGL) are a few key highlights from the biotech sector during the past week.
- Zacks
Rigel (RIGL) wAIHA Study Fails to Meet Goals, Stock Tanks
Rigel (RIGL) phase III study evaluating fostamatinib in patients with warm autoimmune hemolytic anemia did not demonstrate statistical significance in the primary efficacy endpoint.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
